Edward A. Fon
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease.
Journal: Neurobiology of disease
Published: March 29, 2026
An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons.
Journal: Methods (San Diego, Calif.)
Published: February 06, 2026
A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils.
Journal: Methods (San Diego, Calif.)
Published: February 06, 2026
MTFR1L is a cardiac antiaging factor for maintenance of mitochondrial homeostasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 23, 2026
STIP1/HOP promotes the formation of cytotoxic α-synuclein oligomers.
Journal: Molecular neurodegeneration advances
Published: November 14, 2025
LRRK2 kinase mediates increased GCase activity in microglia in response to IFNγ-induced proinflammatory stimulation.
Journal: NPJ Parkinson's disease
Published: October 10, 2025
Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes.
Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes.
Journal: NPJ Parkinson's disease
Published: June 23, 2025
α-Synuclein purification significantly impacts seed amplification assay performance and consistency.
α-Synuclein purification significantly impacts seed amplification assay performance and consistency.
Journal: Acta neuropathologica communications
Published: May 07, 2025
Last Updated: 09/26/2026